Abdullah Alajati

1.4k total citations
17 papers, 595 citations indexed

About

Abdullah Alajati is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Abdullah Alajati has authored 17 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Abdullah Alajati's work include Prostate Cancer Treatment and Research (7 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cell Adhesion Molecules Research (3 papers). Abdullah Alajati is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cell Adhesion Molecules Research (3 papers). Abdullah Alajati collaborates with scholars based in Germany, Switzerland and Slovakia. Abdullah Alajati's co-authors include Hellmut G. Augustin, Holger Weber, Thomas Korff, Anna Laib, Arne Bartol, Hanswalter Zentgraf, Sven Christian, Kristian Ikenberg, Günter Finkenzeller and Mélanie Héroult and has published in prestigious journals such as Nature Communications, Circulation Research and Nature Methods.

In The Last Decade

Abdullah Alajati

16 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdullah Alajati Germany 10 366 168 117 114 78 17 595
Katrina M. Welch-Reardon United States 7 319 0.9× 189 1.1× 167 1.4× 129 1.1× 56 0.7× 8 573
Arne Bartol Germany 7 380 1.0× 116 0.7× 134 1.1× 103 0.9× 115 1.5× 10 771
Byung‐Chul Jeong South Korea 17 431 1.2× 116 0.7× 116 1.0× 144 1.3× 71 0.9× 31 724
Amit Singh Germany 9 359 1.0× 180 1.1× 109 0.9× 89 0.8× 74 0.9× 14 709
Naito Kurio Japan 18 429 1.2× 161 1.0× 84 0.7× 102 0.9× 67 0.9× 39 739
Delphine A. Lacorre United States 6 264 0.7× 112 0.7× 185 1.6× 118 1.0× 59 0.8× 7 618
Sophie Paquet‐Fifield Australia 15 315 0.9× 303 1.8× 94 0.8× 86 0.8× 95 1.2× 18 799
Shawon Debnath United States 8 369 1.0× 113 0.7× 76 0.6× 87 0.8× 95 1.2× 11 679
Jin Qi China 13 371 1.0× 130 0.8× 96 0.8× 316 2.8× 78 1.0× 27 725
Eugène T.P. Verwiel Netherlands 14 425 1.2× 167 1.0× 42 0.4× 145 1.3× 80 1.0× 22 746

Countries citing papers authored by Abdullah Alajati

Since Specialization
Citations

This map shows the geographic impact of Abdullah Alajati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Alajati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Alajati more than expected).

Fields of papers citing papers by Abdullah Alajati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Alajati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Alajati. The network helps show where Abdullah Alajati may publish in the future.

Co-authorship network of co-authors of Abdullah Alajati

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Alajati. A scholar is included among the top collaborators of Abdullah Alajati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Alajati. Abdullah Alajati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Krausewitz, Philipp, et al.. (2024). The relevance of circRNAs in serum of patients undergoing prostate biopsy. International Journal of Urology. 31(5). 578–580.
2.
Klümper, Niklas, Philipp Krausewitz, Abdullah Alajati, et al.. (2023). Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers. Cancers. 15(6). 1890–1890. 3 indexed citations
3.
Eckstein, Markus, Niklas Klümper, Anja Schmidt, et al.. (2023). CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression. Scientific Reports. 13(1). 73–73. 3 indexed citations
4.
Ellinger, Jörg, Abdullah Alajati, Peter Kubatka, et al.. (2022). Prostate cancer treatment costs increase more rapidly than for any other cancer—how to reverse the trend?. The EPMA Journal. 13(1). 1–7. 31 indexed citations
5.
Tolkach, Yuri, Gábor Lotz, Matthias Schmid, et al.. (2022). Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer. Cancers. 14(18). 4441–4441. 8 indexed citations
6.
Golubnitschaja, Olga, Peter Kubatka, Alena Mazuráková, et al.. (2022). Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. Cancers. 14(3). 675–675. 11 indexed citations
7.
Engler, Tobias, Hubert Schorle, Jörg Ellinger, et al.. (2021). The new tumor biomarker miRNA-371-3p is involved in mediating cisplatin resistance in testicular germ cell tumor cell lines. European Urology. 79. S907–S907. 1 indexed citations
8.
Frey, Lisa, Niklas Klümper, Doris Schmidt, et al.. (2021). CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma. Cancers. 13(9). 2177–2177. 22 indexed citations
9.
Klümper, Niklas, Johannes Stein, Doris Schmidt, et al.. (2020). Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers. Cancers. 12(11). 3439–3439. 6 indexed citations
10.
Alajati, Abdullah, Jingjing Chen, & Andrea Alimonti. (2017). CDCP1 initiates tumorigenesis and cooperates with PTEN loss to promote senescence evasion and prostate cancer progression. Annals of Oncology. 28. v1–v1. 2 indexed citations
11.
Revandkar, Ajinkya, Alberto Toso, Abdullah Alajati, et al.. (2016). Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nature Communications. 7(1). 13719–13719. 41 indexed citations
12.
Alajati, Abdullah, Ilaria Guccini, Sandra Pinton, et al.. (2015). Interaction of CDCP1 with HER2 Enhances HER2-Driven Tumorigenesis and Promotes Trastuzumab Resistance in Breast Cancer. Cell Reports. 11(4). 564–576. 50 indexed citations
13.
Alajati, Abdullah, Nina Sausgruber, Nicola Aceto, et al.. (2013). Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant. Cancer Research. 73(17). 5320–5327. 52 indexed citations
14.
Laib, Anna, Arne Bartol, Abdullah Alajati, et al.. (2009). Spheroid-based human endothelial cell microvessel formation in vivo. Nature Protocols. 4(8). 1202–1215. 114 indexed citations
15.
Alajati, Abdullah, Anna Laib, Holger Weber, et al.. (2008). Spheroid-based engineering of a human vasculature in mice. Nature Methods. 5(5). 439–445. 165 indexed citations
16.
Alajati, Abdullah, Holger Weber, Toru Miki, et al.. (2007). The BTB-Kelch Protein KLEIP Controls Endothelial Migration and Sprouting Angiogenesis. Circulation Research. 100(8). 1155–1163. 28 indexed citations
17.
Ocker, Matthias, Abdullah Alajati, Marion Ganslmayer, et al.. (2005). The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells. Journal of Cancer Research and Clinical Oncology. 131(6). 385–394. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrina M. Welch-Reardon Breakdown of academic impact, for papers by Arne Bartol Breakdown of academic impact, for papers by Byung‐Chul Jeong Breakdown of academic impact, for papers by Amit Singh Breakdown of academic impact, for papers by Naito Kurio Breakdown of academic impact, for papers by Delphine A. Lacorre Breakdown of academic impact, for papers by Sophie Paquet‐Fifield Breakdown of academic impact, for papers by Shawon Debnath Breakdown of academic impact, for papers by Jin Qi Breakdown of academic impact, for papers by Eugène T.P. Verwiel
Rankless by CCL
2026